Biotie Therapies Stocks List
|LXRX||D||Lexicon Pharmaceuticals, Inc.||0.83|
|CANF||D||Can-Fite Biopharma Ltd Sponsored ADR (Israel)||4.81|
|VTVT||C||vTv Therapeutics Inc.||-0.82|
|SBIO||F||ALPS Medical Breakthroughs ETF||2.64|
|IBBJ||F||Defiance Nasdaq Junior Biotechnology ETF||0.98|
|XBI||F||SPDR Series Trust SPDR S&P Biotech ETF||0.89|
|IHE||C||iShares U.S. Pharmaceutical ETF||0.88|
|BOSS||B||Global X Funds Global X Founder-Run Companies ETF||0.65|
View all Biotie Therapies related ETFs...
Biotie Therapies was a Finnish biotechnology and pharmaceutics company that was acquired by Acorda Therapeutics in January 2016. The company's research and development was focused on drugs for neurodegenerative and psychiatric disorders like Parkinson's disease, Alzheimer's disease and other cognitive disorders, alcohol and drug dependence and post traumatic stress disorder, and inflammatory and fibrotic liver disease. The company's headquarters is in Turku, Western Finland, and it is listed on NASDAQ OMX Helsinki.